English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 94559/125088 (76%)
Visitors : 29781395      Online Users : 299
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    政大機構典藏 > 理學院 > 心理學系 > 期刊論文 >  Item 140.119/74844
    Please use this identifier to cite or link to this item: http://nccur.lib.nccu.edu.tw/handle/140.119/74844

    Title: Differential effects of dopamine receptor subtype-specific agonists with respect to operant behavior maintained on a differential reinforcement for low-rate responding (DRL) schedule
    Authors: 廖瑞銘
    Liao, Ruey-Ming
    Chiang, Feng-Kuei
    Cheng, Ruey-Kuang
    Contributors: 心理系
    Keywords: Operant psychopharmacology;SKF38393;Quinpirole;Bromocriptine;PD168077
    Date: 2015-03
    Issue Date: 2015-04-27 15:32:00 (UTC+8)
    Abstract: Previous studies have shown that d-amphetamine, a dopamine (DA) indirect agonist, alters operant responding with respect to the behavior maintained on a differential reinforcement of low-rate (DRL) schedule of reinforcement. These behavioral changes have been presumed to result from drug-induced hyperdopaminergia that leads to activation of DA receptors. This study investigated the acute dose effects of DA receptor subtype-selective agonists on the performance of DRL 10-sec behavior by rats. SKF38393 (a D1 receptor agonist) and quinpirole (a D2/D3 receptor agonist) were able to dose-dependently disrupt DRL 10-sec behavior by decreasing the total responses, the non-reinforced responses, and the peak rate of response. Bromocriptine (a D2/D3 receptor agonist) produced a significantly different pattern of behavioral changes when examined during two distinct time phases (15 min and 3 hr after the drug injection). DRL responding was only altered at higher doses of bromocriptine in the second phase as indicated by decreasing reinforced responses and peak rate, together with an increase of burst responses. In contrast to the D1 and D2/D3 receptor agonists, PD168077 (a D4 receptor agonist) did not affect DRL 10-sec behavior. None of these tested drugs affected DRL 10-sec behavior in a manner similar to that of d-amphetamine. These findings show that there are differential effects on the performance of DRL 10-sec behavior when drugs are able to preferentially activate D1, D2/D3 and D4 receptors, supporting the assertion that there is functional heterogeneity of the DA receptor subtypes.
    Relation: Pharmacology, Biochemistry and Behavior, 130, 67-76
    Data Type: article
    DOI 連結: http://dx.doi.org/10.1016/j.pbb.2015.01.002
    DOI: 10.1016/j.pbb.2015.01.002
    Appears in Collections:[心理學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    67-76.pdf1033KbAdobe PDF705View/Open

    All items in 政大典藏 are protected by copyright, with all rights reserved.

    社群 sharing

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback